|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61K 31/505 | (2013.01) | ||
| A61P 15/10 | (2006.01) | ||
| A61P 15/10 | (2018.01) |
| (11) | Number of the document | 3654983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18740208.6 |
| Date of filing the European patent application | 2018-07-12 | |
| (97) | Date of publication of the European application | 2020-05-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/068992 |
| Date | 2018-07-12 |
| (87) | Number | WO 2019/016074 |
| Date | 2019-01-24 |
| (30) | Number | Date | Country code |
| 201762533448 P | 2017-07-17 | US |
| (72) |
WHITTAKER, Andrew , GB
SANGANEE, Hitesh, Jayantilal , GB
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | MPO INHIBITORS FOR USE IN MEDICINE |
| MPO INHIBITORS FOR USE IN MEDICINE |